Insights On Upstream Manufacturing
-
Intensifying CHO Fed-Batch With N-1 Perfusion: 14 To 10 Days
11/5/2026
Seeding production from an N-1 perfusion step cut a CHO fed-batch run from 14 days to 10, with product quality largely consistent, using standard equipment and minimal development effort.
-
Building A Resilient Supply Chain For Complex IVD Reagents (Or Proteins)
11/3/2026
Explore how matching expression systems to diagnostic protein needs can improve yield, consistency, and scalability while reducing supply risks for IVD assays.
-
Cytovance Capabilities Update October 2026: Large Molecule
11/3/2026
Move biologics from research and development toward commercialization with integrated development, analytics, scalable GMP manufacturing, and early-phase fill-finish capabilities.
-
From Blind Spots To Insights: Real-Time Monitoring Of Stem Cell Biology
11/3/2026
Stem cell state changes often occur between sampling points. Continuous, non-invasive metabolic readouts show when those shifts happen without disturbing the culture or sacrificing cells.
-
Advances In ADC Development And Manufacturing
11/3/2026
ADC manufacturability starts at molecule design, not downstream rescue. Learn how operator exposure to high-potency payloads shapes how conjugation workflows are built and qualified.
-
Between The Samples: Seeing Cell Culture As It Happens
11/3/2026
Periodic sampling can miss transient metabolic shifts in cell expansion. Time-resolved glucose and lactate profiles help define candidate process parameters, and those parameters then inform decisions about automated culture operations.
-
Rev Up AAV Production: Optimized Transfection Solutions To Start Strong
11/3/2026
Transfection sets the ceiling for usable AAV at harvest. Optimizing the reagent system and complex stability raises titer and percent full capsids across serotypes, cell lines, and bioreactor scales.
-
Control With A Plus: A New Tool To Improve Your Bioprocess Runs
11/3/2026
Reproducibility becomes more consequential as a process scales from development to manufacturing. Replicate-CHO runs test how consistently one controller maintains process parameters, growth, metabolism, and antibody yield.
-
Streamlining Clonal Cell Line Selection With Susan Sharfstein, Ph.D.
11/2/2026
In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Susan Sharfstein, Ph.D., a professor of nanoscale science and engineering at the University at Albany’s College of Nanotechnology, Science, and Engineering.
-
From iPSC Starting Material to Scalable GMP Manufacturing
11/2/2026
This webinar offers practical insight into reducing process-development complexity and creating a clearer path from product development to clinical production.